You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

17 Results
Drug
Other Name(s): Vidaza®
Quick Link(s): Drug Monograph, Patient Info Sheet
Aug 2023
Drug
Other Name(s): Venclexta®
Quick Link(s): Drug Monograph, Patient Info Sheet
May 2024
Drug
Other Name(s): Rydapt®
Quick Link(s): Drug Monograph, Patient Info Sheet
Jun 2022
Drug
Other Name(s): Oncaspar®
Quick Link(s): Drug Monograph, Patient Info Sheet
Dec 2022
Drug
Other Name(s): Besponsa®
Quick Link(s): Drug Monograph, Patient Info Sheet
Jul 2023
Drug
Other Name(s): Unituxin®
Quick Link(s): Drug Monograph
Jun 2023
Drug
Other Name(s): Mylotarg®
Quick Link(s): Drug Monograph, Patient Info Sheet
Jun 2022
Drug
Other Name(s): Xospata®
Quick Link(s): Drug Monograph, Patient Info Sheet
Jul 2023
Drug
Other Name(s): Vyxeos®
Quick Link(s): Drug Monograph, Patient Info Sheet
Dec 2023
Drug
Other Name(s): Tepadina®
Quick Link(s): Drug Monograph
Jan 2023
Regimen
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's High Grade, 
Lymphoma - Non-Hodgkin's Intermediate Grade
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
New Drug Funding Program
    Epcoritamab (Outpatient) - Relapsed or Refractory Diffuse Large B-Cell Lymphoma
High Cost Therapy Funding Program
    Epcoritamab (Inpatient) - Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
epcoritamab
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Nov 2024
Regimen
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's High Grade, 
Lymphoma - Non-Hodgkin's Intermediate Grade
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
New Drug Funding Program
    Glofitamab (Outpatient) - Relapsed or Refractory Diffuse Large B-cell Lymphoma
High Cost Therapy Funding Program
    Glofitamab (Inpatient) - Relapsed or Refractory Diffuse Large B-cell Lymphoma
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
oBINutuzumab,
glofitamab
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Sep 2024

Pages